DAY 1 : Thursday June 22, 2023 | | |
8:00-9:00 | Breakfast | |
9:00-9:15 | Introductions and CCIC Update | Matthew Hill, CCIC Executive Director |
SESSION 1: Basics and Biology of Cannabinoids and the Endocannabinoid System | | |
9:15-10:00 | Endocannabinoids 101 | Cecilia Hillard, PhD |
10:00-10:30 | Update on CBD Research | Ruth Ross, PhD |
10:30-10:50 | Health and Coffee Break | |
10:50-11:20 | The Complex Pharmacology of Cannabinoids and Terpenoids Beyond Delta9-tetrahydrocannabinol and Cannabidiol | Robert Laprairie, PhD |
Trainee Research Award Presentations | | |
11:20-11:35 | Inhaled Cannabis Delivery During Pregnancy: Characterizing the Neurodevelopmental, Metabolic, and Behavioural Outcomes in Male and Female Rats | Samantha Baglot, PhD Candidate |
11:35-11:50 | The Effect of Acute Cannabis Exposure on Microglia (the Brain's Innate Immune Cells) | Haley Vecchiarelli, PhD |
11:50-13:00 | Lunch | |
SESSION 2: Non-Medical Cannabis Use and Health Impacts | | |
13:00-13:30 | Influences of Genetic Variants on Acute Responses to Smoked Cannabis | Justin Matheson, PhD |
13:30-14:00 | Navigating the Weeds: Chronic and Acute Effects of High-Potency Concentrates vs. Flower on Cognition | Carrie Cuttler, PhD |
14:00-14:30 | Predicting Problematic Cannabis Use in a Young Adult Population | Kim Hellemans, PhD |
14:30-16:00 | Poster Session | |
Trainee Research Award Presentation | | |
16:00-16:15 | Trends in Cannabis Use, Blood Pressure and Hypertension in Middle-Aged Adults: Findings from NHANES, 2009-2018 | Jamie Corroon, ND, PhD |
16:15-17:15 | Panel Discussion: Managing Cannabis in Patients with Mental Illness & Patients with CUD | |
17:15-17:45 | AGM | |
17:15-18:30 | Networking Social | |
| DAY 1 CLOSES | |
| | |
Day 2: Friday June 23, 2023 | | |
8:00-9:00 | Breakfast | |
SESSION 3: Medical Cannabis and Therapeutic Targets | | |
9:00-9:30 | AEF0117: A Novel Potential Treatment for Cannabis Use Disorder | Margaret Haney, PhD |
9:30-10:00 | The Role of Cannabinoids in the Treatment of Epilepsy: More than Millennia in the Making | Elizabeth Thiele, MD, PhD |
10:00-10:30 | PTSD & Cannabis | Matthew Hill, PhD |
10:30-11:00 | Health and Coffee Break | |
11:00-11:30 | Updated Clinical Overview on Pain | Hance Clarke, MD, PhD, FRCPC |
11:30-12:30 | Panel Discussion: Focus on Pain Conditions | |
12:30-13:30 | Lunch | |
SESSION 4: Harm Reduction and Public Health Implications of Cannabis Legalization | | |
13:30-14:15 | Should Cannabis THC Standard Units be Established in Canada? Considerations for Consumers, Industry, and Regulators | David Hammond, PhD |
14:15-14:30 | Health Canada Update on the Non-Therapeutic Research on Cannabis Framework | Sophie-Anne Lamour, PhD |
14:30-15:00 | Cannabis and Problematic Substance Use: New Finding on Substitution and Harm Reduction From High Risk Populations | Zachary Walsh, PhD |
15:00-16:30 | Poster Session | |
Trainee Research Award Presentation | | |
16:30-16:45 | Breaking Down Silos of Medical and Non-medical Cannabis: A Quebec Study About Use in People Living With Chronic Pain | Claudie Audet, BSc, TS |
16:45-17:00 | Health Canada Update: How Has Cannabis Legalization Impacted Public Health? | George Mammen, PhD |
17:00-17:30 | Cannabis Use During the COVID-19 Pandemic | Sameer Imtiaz, PhD |
17:30 | CONGRESS CLOSES | |
| | |